Remove 2024 Remove Pricing Remove Sales Remove Venture Capital
article thumbnail

Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More

Xconomy

An April report from Evaluate Pharma predicted sales of orphan drugs to rise 12 percent a year between now and 2024, when they will account for an estimated 20 percent of worldwide prescription drug sales. The market for drugs for rare or “orphan” diseases continues to grow.

Pricing 97